Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sedation Efficacy of Dexmedetomidine Versus Midazolam in Critically Ill Ventilated Children

NCT04082767 is registered in ClinicalTrials.gov with Douglas Fraser as lead sponsor.

NCT NCT04082767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04082767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sedation Efficacy of Dexmedetomidine Versus Midazolam in Critically Ill Ventilated Children
Lead sponsor
Douglas Fraser
Phase
Phase 3
Overall status
Unknown status
Start date
June 8, 2021
Completion date
September 30, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mechanically ventilated, critically ill children